Relation Therapeutics Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-09.
Relation Therapeutics Inc. filed a Form D notice of an exempt securities offering with the SEC on December 9, 2025. The filing reports $36.17M sold. Its industry group is Biotechnology. It names Charles Roberts (Director), David Roblin (Executive Officer, Director), Casey Swerner (Executive Officer) (SEC Form D, December 9, 2025).
Sell to companies like Relation Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Relation Therapeutics Inc.
Free to see. No signup.
More on the people and the money behind Relation Therapeutics Inc., from the filings we hold.
Biotechnology raises by companies based in Florida, filed in December 2025, largest first.
Get an email when Relation Therapeutics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Relation Therapeutics Inc. raises, hires or launches. No email unless you switch it on.
Watch Relation Therapeutics Inc. →Get the full cited report on Relation Therapeutics Inc.
What the filing shows about Relation Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Relation Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Relation Therapeutics Inc. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $36.17M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Charles Roberts is named as Director on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
David Roblin is named as Executive Officer and Director on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
Casey Swerner is named as Executive Officer on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
Jim Mellon is named as Director on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
Christine Aylward is named as Director on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
Jason Pontin is named as Director on the Form D that Relation Therapeutics Inc. filed with the SEC on 9 December 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-12-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Relation Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Relation Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Relation Therapeutics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Relation Therapeutics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Relation Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Relation Therapeutics Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Miami
https://mentionfox.com/funding/relation-therapeutics-inc-form-d-25000001